Cytosorbents Corporation
CTSO
$0.61
$0.023.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.20M | -10.27M | -9.87M | -16.11M | -20.72M |
| Total Depreciation and Amortization | 1.63M | 1.67M | 1.70M | 1.71M | 1.74M |
| Total Amortization of Deferred Charges | 820.00K | 762.00K | 762.00K | 560.70K | 381.00K |
| Total Other Non-Cash Items | -5.60M | -949.00K | -3.30M | 3.87M | 8.55M |
| Change in Net Operating Assets | -1.03M | -1.11M | 929.00K | -3.09M | -4.38M |
| Cash from Operations | -12.38M | -9.89M | -9.78M | -13.06M | -14.43M |
| Capital Expenditure | -164.00K | -125.00K | -260.00K | -240.90K | -284.00K |
| Sale of Property, Plant, and Equipment | 76.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -327.00K | -123.00K | -342.00K | -348.30K | -385.00K |
| Cash from Investing | -415.00K | -248.00K | -602.00K | -589.20K | -669.00K |
| Total Debt Issued | 2.48M | 0.00 | 0.00 | 15.00M | 15.00M |
| Total Debt Repaid | -- | 0.00 | 0.00 | -4.38M | -5.00M |
| Issuance of Common Stock | 6.83M | 7.00M | 7.00M | 7.00M | 220.20K |
| Repurchase of Common Stock | -1.10K | -1.10K | -42.10K | -41.20K | -41.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -58.00K | -848.00K | -848.00K |
| Cash from Financing | 9.31M | 7.00M | 6.90M | 16.73M | 9.33M |
| Foreign Exchange rate Adjustments | 1.49M | 33.00K | 264.00K | -64.90K | -85.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.99M | -3.11M | -3.22M | 3.02M | -5.85M |